fda warning letters compounded semaglutide telehealth 2024 2025 Drug Recalls and Warnings: Recalls for and Tirzepatide, Wegovy; Facility Troubling Findings in Study of

Staying hydrated may help you feel more comfortable while taking your medication

-Dose response, GI tolerance, Adherence, and outcomes across different dietary patterns and BMI phenotypes will matter more than headline percentages

American Diabetes Association, Grant/Award Number: 1-17-ICTS-059 Footnotes DISCLOSURE None declared

Dose-by-dose weight loss in Phase 2 (NEJM) Phase 2 NEJM weight loss by dose, 24 and 48 weeks Dose 1 mg 24 weeks -7.2% 48 weeks -8.7% Dose 4 mg 24 weeks -12.9% 48 weeks -17.5% Dose 8 mg 24 weeks -15.7% 48 weeks -22.8% Dose 12 mg 24 weeks -17.5% 48 weeks -24.2% Dose Placebo 24 weeks -1.6% 48 weeks -2.1% Source: Jastreboff et al., NEJM 2023

10 units = 0.1 mL